Results 161 to 170 of about 10,590 (201)

Macrophage migration inhibitory factor: Exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks (Review). [PDF]

Int J Mol Med
Camacho Meza G, Avalos Navarro G, De La Cruz Mosso U, Ramírez Patiño R, Muñoz Valle JF, Bautista Herrera LA.   +5 more
europepmc   +1 more source

Dual targeting of CXCR4 and EZH2 in endometriosis. [PDF]

iScience
Brunty S, Wagner K, Fleshman T, Ruley M, Mitchell B, Santanam N.   +5 more
europepmc   +1 more source

Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression. [PDF]

Front Oncol
Liu P, Sun Z.
europepmc   +1 more source

Chemokines and their receptors in oral squamous cell carcinoma: mechanisms, clinical significance, and therapeutic implications. [PDF]

Front Immunol
Li D, Chen S, Ji J, Wang Z, Zhou H, Liao Z, Tang Q.   +6 more
europepmc   +1 more source

Protective Effect of CXCR7 Against Hypoxia/Reoxygenation Injury in Renal Tubular Epithelial Cells. [PDF]

Cell Biochem Biophys
Meng P, Liu C, Li J, Fang P, Chen L.
europepmc   +1 more source

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity. [PDF]

Cell Death Dis
Liu CC, Yang WB, Chien CH, Wu CL, Chuang JY, Chen PY, Chu JM, Cheng SM, Qiu LY, Chang YC, Hwang DY, Huang CY, Lee JS, Chang KY.   +13 more
europepmc   +1 more source

Roles of Macrophage Migration Inhibitory Factor (MIF) Signaling Pathway in Oncovirus Infection and Virus-Associated Cancers. [PDF]

Viruses
Fan J, Ryu V, Qin Z, Dai L.
europepmc   +1 more source

CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension. [PDF]

J Thorac Dis
Xu J, Miao S, Wu T, Hu C, Huang D, Zhang X.   +5 more
europepmc   +1 more source

The Use of Biologics for Targeting GPCRs in Metastatic Cancers. [PDF]

BioTech (Basel)
McBrien C, O'Connell DJ.
europepmc   +1 more source

Chemokines in Pregnancy. [PDF]

Biomolecules
Shevchenko JA, Gizbrekht AA, Sennikov SV.   +2 more
europepmc   +1 more source